创新链/学科链/研发链/产业链

新药研发前沿动态 / 医药领域趋势进展

新型冠状病毒肺炎治疗中的药物不良反应与防治

Prevention and Treatment of Adverse Drug Reactions in COVID-19

  • 摘要: 围绕《新型冠状病毒感染的肺炎诊疗方案(试行第六版)》中的治疗试用药物,包括抗病毒药物、糖皮质激素和中药,从各药的作用机制、药物相互作用、药物不良反应等方面,综述新型冠状病毒肺炎(COVID-19)治疗中可能出现的不良反应及防治策略,为临床治疗方案的合理选择提供参考。

     

    Abstract: Based on the medication regimens recommended by Diagnosis and Treatment Scheme for COVID-19 (Trial Version 6.0), including antiviral drugs, corticosteroids and traditional Chinese medicines, this article reviews the possible adverse reactions and their prevention and treatment strategy during the treatment of COVID-19 in terms of the mechanisms of action, drug interactions and adverse drug reactions, aiming to provide reference for the selection of reasonable therapeutic regimens.

     

/

返回文章
返回